BIOMARIN PHARMACEUTICAL INC (BMRN)

US09061G1013 - Common Stock

87.34  -1.27 (-1.43%)

After market: 87.34 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
1.846B
-0.76%
2.096B
13.52%
2.419B
15.42%
2.816B
16.40%
EBITDA
YoY % growth
24.2M
175.00%
166.6M
588.43%
262.483M
57.55%
513.44M
95.61%
EBIT
YoY % growth
-83.8M
13.07%
64.6M
177.09%
158.097M
144.73%
393.71M
149.03%
Operating Margin
-4.54%3.08%6.54%13.98%
EPS
YoY % growth
-0.36
-107.91%
0.29
180.56%
0.95
227.59%
1.68
76.71%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26
EPS
Q2Q % growth
0.34
26.56%
Revenue
Q2Q % growth
663.76M
11.29%
EBITDA
Q2Q % growth
98.173MN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
82.684M
39.43%
N/AN/AN/AN/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth
0.18
∞%
0.24-0.06-24.46%
Q3 2023
Q2Q % growth
0.21
625.00%
0.24-0.03-12.05%
Q2 2023
Q2Q % growth
0.29
93.33%
0.240.0522.09%
Q1 2023
Q2Q % growth
0.27
50.00%
0.180.0947.54%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth
646.207M
20.22%
649.62M-3.413M-0.53%
Q3 2023
Q2Q % growth
581.3M
15.04%
620.85M-39.55M-6.37%
Q2 2023
Q2Q % growth
595.3M
11.52%
607.14M-11.84M-1.95%
Q1 2023
Q2Q % growth
596.4M
14.82%
582.04M14.36M2.47%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-8.76% -9.75% -20.13% -18.11%
Revenue-0.8% -1.02% -2.46% -3.16%